RGTI · Rigetti Computing, Inc. — research history

Stage produced output that could not be parsed as a valid JSON object. ~6h cooldown before retry.

{"symbol":"RGTI","company":"Rigetti Computing, Inc.","investigation_summary":"The 5-Form-4 trigger is almost entirely noise: the CEO (Kulkarni) and CTO (Rivas) were exercising vested options at sub-$2 strike prices and selling shares to cover exercise costs and taxes — this is not new-money conviction buying. Directors received annual RSU grants vesting in 2027, also no cash outlay. One director (

The investigation reveals that the Form 4 cluster triggering this analysis consists overwhelmingly of noise — RSU grants (at $0 exercise price) to directors and routine sell-to-cover transactions for tax withholding on vesting equity. The two 'real trades' flagged by the pipeline are CTO David Rivas exercising options and immediately selling 499,328 shares at ~$25.40 (a net SELL), and CEO Subodh Kulkarni exercising options and simultaneously selling shares to cover exercise costs — both consistent with routine compensation management during a price spike, NOT conviction open-market buys. The CHIPS Act $100M non-binding LOI is a legitimate catalyst but carries dilution risk at the 15% discounted implied pricing formula. Revenue remains ~$4.4M/quarter against a near-zero gross margin and massive R&D burn ($20M/quarter). No genuine mispricing exists — the stock trades on quantum computing narrative premium with no path to profitability in sight.

Rigetti Computing trades at $19.31 (spot ~$19.47), sitting just above its 50 DMA ($19.08) but meaningfully BELOW the 200 DMA of $23.61 — giving a 27.9% MOS vs. 200DMA on any CSP strike below that level. The stock has pulled back sharply from its 52w high of $56.34 (-65.7%) following a quantum-sector pump-and-dump in Q4 2025, and RSI at 44.8 is neutral (neither oversold nor overbought). Earnings for Q2 2026 print approximately early-August — AFTER all near-term expiry windows, so no IV crush concern there. The $100M CHIPS Act LOI ($72M net after the 15% discount on share issuance) announced May 21 provides a fundamental floor. The wheel-hunter signal flagged an extraordinary annualized yield of ~82.8% on the Jul-17 17P — but CRITICAL WARNING: the options chain data returned zero bid/ask values for all strikes, indicating either stale or illiquid market-making in RGTI's near-dated options. OI is present (2,082 at $17P) confirming real interest, yet without verifiable current bids/asks, spread quality cannot be confirmed. If filled at last traded price ($1.35 on the 17P), annualized yield easily clears the 15% threshold; but market-makers may be wide. The IV rank is unknown (tool did not return IV rank percentile explicitly) but ATM IV in the chain shows anomalous low readings (~3-12%) inconsistent with a speculative quantum name that has averaged $39M/day in volume — another sign of data quality issues at the market-maker level rather than genuine compressed vol.

RGTI is a sub-$7B quantum computing company with -5.9x operating margins, negative FCF, and declining revenues ($10.8M → $7.1M YoY). The stock has run +85% over the past year on CHIPS Act funding speculation but trades 10.7% below its 200DMA — technically neutral rather than extended. Earnings risk is clear: next print likely Q2 2026 (~Aug), well outside a July expiry window. The options chain shows deeply illiquid contracts with bid=0 and ask=0 across every strike at Jul-10, Jul-17, and Jul-24 expiries — meaning the $19P (OI 8935) and $20P (OI 13,604) trades visible in aggregate data are OTC/dark pool transactions where real execution spreads cannot be verified. The annualized yield of ~111% on a CSP is a theoretical calculation against premium collected; actual fills will incur significant slippage that could cut the effective yield by half or more. IV appears modest (6–12% implied) rather than elevated relative to realized vol regime for this name, and IV rank cannot be reliably estimated given zero visible bid-ask on any listed contract.

Investigation triggered by a cluster of 5 Form 4 filings in 14 days — but detailed review reveals this is predominantly selling activity (CTO Rivas exercised options and sold ~$12.7M at $25.40 avg; CEO Kulkarni exercised options and sold ~$2.6M net at $26.23/$24.38 averages), not conviction open-market purchases. The CHIPS Act LOI for up to $100M is a real catalyst but already priced in after the stock surged +46% in May alone from ~$16 to $24. At an $8B market cap against ~$10M TTM revenue (EV/Revenue ~760x, forward P/E negative), there is no traditional mispricing — this is purely sentiment and narrative driven. The fundamental case for asymmetry fails: the stock is near its 52w high, IV is elevated on the recent volatility but chain data shows very wide bid-ask spreads suggesting illiquid options, and the smart-money signal is actually a bearish counter-indicator given insider selling at these levels.

The investigation trigger cited three Form 4 filings in 14 days, but upon detailed review of filing text, all three transactions were SELLING activity — not purchases. The CFO sold 3,682 shares (sell-to-cover RSU taxes), the CTO sold 18,759 shares (sell-to-cover RSU taxes), and a Director exercised and sold 50,000 warrants under a pre-adopted 10b5-1 plan from March 2025. This is not smart-money buying; it is standard executive compensation settlement. Rigetti recently surged ~48% on $100M in CHIPS Act quantum funding (May 2026), trading at an extreme forward P/E of -133x with deeply negative EBITDA, FCF burn of ~$6.2M/quarter, and a market cap of ~$8.98B that prices in commercial-scale quantum computing revenue years before any meaningful top-line exists.

Four active anti-signal gates (going concern, structural dilution, accounting-driven earnings, government concentration) and deeply negative fundamentals override the CHIPS Act catalyst. The equity-structured funding and zero insider conviction make this a speculative trap, not an investable setup.

Rigetti Computing announced a $100 million CHIPS Act LOI with the US Department of Commerce on May 20-21, 2026 — a significant government endorsement of its superconducting quantum computing program. The stock surged +30.6% to $22.04 on the news in heavy volume (144M+ shares). However, the stock is deeply unprofitable (forward P/E of -108), trades at a ~690x EV/revenue multiple on TTM revenues of only $10M, and has burned cash consistently. The equity issuance structure (DOJ receives discounted shares) implies dilution for existing holders. Insiders received option/RSU grants in March 2026 but filed tax-related sales rather than open-market buys — no conviction-level insider purchasing signal exists. The stock is now ~62% below its October 2025 high of $58.15 and has been in a volatile descending channel since that peak, making it range-bound with elevated IV rather than an asymmetric long.

Extreme valuation disconnect ($6.4B cap vs ~$10M revenue), negative earnings, and active anti-signal gates (warrant dilution and accounting distortions) render this a speculative trap rather than a tradable setup. The market's bearish pricing is justified by deteriorating fundamentals and lack of smart-money conviction.

Rigetti is a pre-profit pure-play quantum computing company trading at an $6.4B market cap with only ~$10M TTM revenue (down 34% YoY). The stock has collapsed ~66% from its October 2025 all-time high of ~$58 to current $19, driven by sector rotation out of speculative names and skepticism over near-term quantum monetization. Q1 FY2026 showed strong sequential revenue acceleration ($4.4M vs $1.47M YoY) but the stock fell on the print because forward guidance implied slowing growth. The company has ~$569M in cash (massive relative to burn), no debt, and recently launched its 108-qubit Cepheus-1 system — but the fundamental disconnect between valuation ($6B cap vs $7-10M revenue) and speculative narrative is extreme. No insider open-market purchases were detected in the past 90 days; all recent Form 4s relate to RSU vesting/exercises, not directional bets by insiders.